STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells
- PMID: 15919761
- DOI: 10.1096/fj.04-3099fje
STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells
Abstract
Aberrantly enhanced vascular endothelial growth factor (VEGF) gene expression is associated with increased tumor growth and metastatic spread of solid malignancies, including human renal carcinomas. Persistent activation of STAT3 is linked to tumor-associated angiogenesis, but underlying mechanisms remain unclear. Therefore, we examined whether STAT3 modulates the stability and activity of hypoxia-inducible factor-1alpha (HIF-1alpha), and in turn enhances VEGF expression. We found that STAT3 was activated in ischemic rat kidneys and hypoxic human renal carcinoma cells. We also found that hypoxia-induced activation of STAT3 transactivated the VEGF promoter and increased the expression of VEGF transcripts. Consistent with these findings, STAT3 inhibition attenuated the hypoxic induction of VEGF. Interestingly, activated STAT3 increased HIF-1alpha protein levels due to the HIF-1alpha stability by blocking HIF-1alpha degradation and accelerated its de novo synthesis. The novel interaction of STAT3 with HIF-1alpha was identified in hypoxic renal carcinoma cells. Furthermore, hypoxia recruited STAT3, HIF-1alpha, and p300 to the VEGF promoter and induced histone H3 acetylation. Therefore, these findings provide compelling evidence that a causal relationship exists between STAT3 activation and HIF-1-dependent angiogenesis and suggest that therapeutic modalities designed to disrupt STAT3 signaling hold considerable promise for the blocking tumor growth and enhancing apoptosis of cancer cells and tissues.
Similar articles
-
Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.J Cell Biochem. 2005 Apr 1;94(5):857-63. doi: 10.1002/jcb.20367. J Cell Biochem. 2005. PMID: 15669079
-
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.Mol Pharmacol. 2007 Aug;72(2):395-406. doi: 10.1124/mol.106.032920. Epub 2007 May 8. Mol Pharmacol. 2007. PMID: 17488804
-
Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.Mol Cancer Res. 2007 Apr;5(4):321-9. doi: 10.1158/1541-7786.MCR-06-0218. Mol Cancer Res. 2007. PMID: 17426247
-
Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing.Curr Med Chem. 2012;19(1):90-7. doi: 10.2174/092986712803413944. Curr Med Chem. 2012. PMID: 22300081 Review.
-
Targeting tumor angiogenesis with histone deacetylase inhibitors.Cancer Lett. 2009 Aug 8;280(2):145-53. doi: 10.1016/j.canlet.2008.11.012. Epub 2008 Dec 25. Cancer Lett. 2009. PMID: 19111391 Free PMC article. Review.
Cited by
-
Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.PLoS One. 2012;7(11):e50394. doi: 10.1371/journal.pone.0050394. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185615 Free PMC article.
-
The role of STAT3 in autophagy.Autophagy. 2015;11(5):729-39. doi: 10.1080/15548627.2015.1017192. Autophagy. 2015. PMID: 25951043 Free PMC article. Review.
-
Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.Oncotarget. 2012 Sep;3(9):1036-48. doi: 10.18632/oncotarget.663. Oncotarget. 2012. PMID: 23013619 Free PMC article.
-
The uPAR System as a Potential Therapeutic Target in the Diseased Eye.Cells. 2019 Aug 18;8(8):925. doi: 10.3390/cells8080925. Cells. 2019. PMID: 31426601 Free PMC article. Review.
-
The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions.Cancers (Basel). 2021 Nov 5;13(21):5557. doi: 10.3390/cancers13215557. Cancers (Basel). 2021. PMID: 34771718 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous